EGFR and lung carcinoma: Although many lines of evidence suggest that EGFR mutations are more common among women, never-smokers, patients with adenocarcinoma-type lung cancer, and patients of East Asian ethnicity including Japanese [11,19], the association of COPD prevalence with EGFR mutations has not been fully evaluated.